CSIMarket
 
Zymergen Inc.  (NASDAQ: ZY)
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare
 

ZY's Market share relative to its competitors, as of Q2 2022

As of Q2 2022 (Revenue in Millions of $)

Date modified: 2026-05-09T09:16:44+00:00





COMPANY NAME REVENUES
12 Months Ending
Q2 2022
MARKET SHARE
12 Months
Q2 2022
MARKET SHARE
MRQ
Q2 2022
MARKET SHARE
A Quarter Before
Q1 2022
Zymergen Inc. 14.55 9.33% 11.91 % 12.55 %
Ginkgo Bioworks Holdings Inc 141.31 90.67% 88.09% 87.45%






ZY's Market share relative to its competitors, as of Q2 2022 within the Healthcare Sector
As of Q2 2022



COMPANY NAME MARKET SHARE
12 Months Ending
Q2 2022
MARKET SHARE
12 Months Ending
Q1 2022
MARKET SHARE
MRQ
Q2 2022
MARKET SHARE

Q1 2022
Zymergen Inc. 9.33% 9.47% 11.91 % 12.55 %
Ginkgo Bioworks Holdings Inc 90.67% 90.53% 88.09% 87.45%



Note: Market share is calculated based on total revenue. To get a more accurate picture of Zymergen Inc.'s market divisions, geographic dispersion, segments, products, and services, visit Zymergen Inc.'s Business Segment.

The list includes publicly traded companies only. More information about the sources of this report can be found here.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.